PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 583 participants.
Also called NCT03222141
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 583 participants
- Sponsor
- Registry
-
NCT03222141
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03222141. Allocation not applicable; no masking; primary purpose treatment. Start 2013-10 (actual); primary completion 2015-09 (actual). Results posted on 2018-08-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7
- Acronym
- PII S3HR/NR7
- Condition
- Symptomatic Severe Aortic Stenosis
- Intervention (Device)
- TAVR Implantation of the THV Prosthesis
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct03222141- Content hash
a628780faf7f93c961d73d318c54e9f7e564903f4ba782708f368beb679fba66